143
Views
2
CrossRef citations to date
0
Altmetric
COMMENTARY

Should We Treat Children with Down Syndrome and Leukemia in the Developing World?

, MD, , DCH, DNB & , DCH, MD
Pages 105-108 | Received 04 Sep 2011, Accepted 19 Dec 2011, Published online: 29 Feb 2012

REFERENCES

  • Jyothi A, Rao GNM, Kumar KSD, Translocation Down syndrome. Ind J Med Sci. 2002;56:225–229.
  • Robison LL. Down syndrome and leukemia. Leukemia. 1992;6:5–7.
  • Iselius L, Jacobs P, Mortan N. Leukemia and transient leukemia in Down syndrome. Hum Genet. 1990;85:477–485.
  • Sachdeva A, Jain V, Yadav SP, Move to alternative medicine why? And when? The Indian scenario [abstract]. Pediatr Blood Cancer. 2005;45:578.
  • Yadav SP, Dua V, Sachdeva A. Sepsis is a major barrier to improving survival in childhood acute lymphoblastic leukemia in the developing world. J Pediatr Hematol Oncol. 2011;33:636.
  • Yadav SP, Ramzan M, Lall M, Sachdeva A. Pediatric acute myeloid leukemia: final frontier for pediatric oncologists in developing world. Pediatr Hematol Oncol. 2011;28:647–648.
  • Gamis AS, Alonzo TA, Hilden JM. Outcome of Down syndrome (DS) children with acute myeloid leukemia (AML) or myelodysplasia (MDS) treated with a uniform prospective clinical trial-Initial report of the COG Trial A2971 [abstract]. Blood. 2006;108:A15.
  • Levitt GA, Stiller CA, Chessells JM. Prognosis of Down's syndrome with acute leukemia. Arch Dis Child. 1990;65:212–216.
  • Ravindranath Y, Abella E, Krischer JP, Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood. 1992;80:2210–2214.
  • Taub JW, Huang X, Matherly LH, Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood. 1999;94:1393–1400.
  • Robison LL, Nesbit MEJ, Sather HN, Down syndrome and acute leukemia in children: a 10-year retrospective survey from Children Cancer Study Group. J Pediatr. 1984;105:235–242.
  • Crombet O, Svarch E. Down syndrome and juvenile myelomonocytic leukemia. Pediatr Hematol Oncol. 1999;16:181–182.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.